Based on this, the examination of IGH::NSD2 fusion transcripts in peripheral blood samples cannot definitively determine whether the signal originates from circulating tumor cells derived from the bone marrow or if it indicates the presence of extramedullary manifestations. This evidence concerns the gene NSD2 and neoplasm.